COPPOLA, Giangennaro
 Distribuzione geografica
Continente #
NA - Nord America 11.874
AS - Asia 7.358
EU - Europa 2.978
SA - Sud America 391
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 7
AN - Antartide 1
Totale 22.680
Nazione #
US - Stati Uniti d'America 11.802
HK - Hong Kong 4.748
CN - Cina 888
UA - Ucraina 860
SG - Singapore 772
IT - Italia 741
VN - Vietnam 457
BR - Brasile 328
RU - Federazione Russa 322
DE - Germania 266
IE - Irlanda 254
SE - Svezia 214
KR - Corea 179
TR - Turchia 173
FI - Finlandia 130
GB - Regno Unito 51
CA - Canada 45
IN - India 44
FR - Francia 35
AR - Argentina 22
JP - Giappone 22
EU - Europa 21
ES - Italia 17
BD - Bangladesh 13
MX - Messico 13
NL - Olanda 13
PL - Polonia 13
CZ - Repubblica Ceca 12
IQ - Iraq 11
NO - Norvegia 11
PY - Paraguay 11
ZA - Sudafrica 11
RO - Romania 10
EC - Ecuador 9
ID - Indonesia 8
MA - Marocco 8
AT - Austria 7
CO - Colombia 7
IL - Israele 7
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DK - Danimarca 4
UY - Uruguay 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
AO - Angola 2
AU - Australia 2
BF - Burkina Faso 2
BG - Bulgaria 2
GN - Guinea 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
PH - Filippine 2
TW - Taiwan 2
UZ - Uzbekistan 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LU - Lussemburgo 1
MC - Monaco 1
MG - Madagascar 1
MT - Malta 1
NC - Nuova Caledonia 1
NP - Nepal 1
Totale 22.666
Città #
Hong Kong 4.743
Ann Arbor 3.045
Wilmington 1.250
Woodbridge 1.105
Jacksonville 992
Houston 968
Chandler 911
Princeton 782
Dallas 406
Dong Ket 382
Dublin 248
Singapore 244
Dearborn 215
Andover 199
Ashburn 188
Mestre 182
Nanjing 174
Pellezzano 162
Izmir 161
Beijing 156
Boardman 136
Moscow 109
Norwalk 74
Fairfield 68
Salerno 68
Düsseldorf 66
Hebei 65
Shenyang 58
Jiaxing 50
Changsha 46
Nanchang 45
Tianjin 41
Nettuno 38
Los Angeles 35
Ho Chi Minh City 33
São Paulo 30
Pune 27
San Diego 26
New York 23
Redwood City 23
Tokyo 22
Council Bluffs 21
Falls Church 21
Seattle 20
Cambridge 17
Munich 17
The Dalles 17
Guangzhou 15
Bari 14
Chicago 14
Stockholm 14
Washington 14
Columbus 13
Milan 13
Toronto 13
Warsaw 13
Brooklyn 12
Jinan 12
Orta Nova 12
Rome 12
Santa Clara 12
Brno 11
Hanoi 11
Venezia 11
Boston 10
Montreal 10
San Francisco 10
Seoul 10
Belo Horizonte 9
Helsinki 9
London 9
Naples 9
Secaucus 9
Asunción 8
Dormagen 8
Edinburgh 8
Nuremberg 8
Saint Petersburg 8
Spinea 8
Atlanta 7
Chennai 7
Hefei 7
Johannesburg 7
Modugno 7
Paris 7
Rio de Janeiro 7
Tappahannock 7
Turku 7
Baghdad 6
Charlotte 6
Ankara 5
Casapesenna 5
Denver 5
Dhaka 5
Hangzhou 5
Madrid 5
Manchester 5
Montréal 5
Napoli 5
Porto Alegre 5
Totale 18.183
Nome #
Kleefstra-variant syndrome with heterozygous mutations in EHMT1 and KCNQ2 genes: a case report 697
Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. 583
Epileptic encephalopathies in children 499
Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy. 495
Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats. 410
Autosomal dominant lateral temporal epilepsy: Absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 354
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 352
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 317
Ketogenic diet for the treatment of catastrophic epileptic encefalopathies in childhood. 311
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome. 282
Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications 269
Mozart's music in children with drug-refractory epileptic encephalopathies: Comparison of two protocols 256
Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. 237
A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. 226
Bone Mineral Density In Children, Adolescents And Young Adults With Epilepsy. 218
Malignant migrating partial seizures in infancy 200
Epilepsy and electroencephalographic anomalies in chromosome 2 aberrations. A review. Epilepsy Res. 2008 Mar;79(1):63-70. Epub 2008 Feb 20. Review 193
Epilessia con crisi parziali migranti dell’infanzia: presentazione di un caso 180
Malignant migrating partial seizures in infancy 153
Infantile spasms in early-onset Niemann-Pick disease with a novel compound heterozygous mutations in SMPD1 gene. 145
Bone and calcium metabolism and antiepileptic drugs 144
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform 140
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 139
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists 135
A Low Cost Amplifier And Acquisition System For Cortical-Electroncephalography In Non-Human Applications 135
Migrating partial seizures in infancy: a malignant disorder with developmental arrest. 134
The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus. 133
Brain changes in Kallmann syndrome 133
Hyperekplexia caused by dominant-negative suppression of glyra1 function. 130
Vaccination and occurrence of seizures in SCN1A mutation-positive patients: A multicenter Italian study 130
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. 129
Different calorie restriction treatments have similar anti-seizure efficacy 129
Antiepileptic drugs, sex hormones, and PCOS 128
Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy. 128
Brain anatomical substrates of mirror movements in Kallmann syndrome. 127
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review 125
Afebrile benign convulsions with mildgastroenteritis: a new entity? 125
Benign convulsions associated with mild gastroenteritis: a multicenter clinical study 125
Treatment of partial seizures in childhood : an overview. CNS Drugs. 125
STATO DI MALE ELETTRICO IN SONNO, DISPLASIA CORTICALE E SINDROME DI COHEN: PRESENTAZIONE DI UN CASO 123
Gastaut type-idiopathic childhood occipital epilepsy and childhood absence epilepsy: a clinically significant association? 123
Successful Treatment of Refractory Seizures with Rufinamide in Children with Schizencephaly: Report of 3 Cases 122
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. 121
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 121
Topiramate in frontal lobe epilepsy. 120
Valutazione dell’efficacia della lamotrigina come farmaco aggiunto nelle epilessie farmacoresistenti dell’età evolutiva: risultati di uno studio aperto 119
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter italian study. 118
Levetiracetam monotherapy for children and adolescents with benign rolandic seizures. 116
Role of folic acid depletion on homocysteine serum level inchildren and adolescents with epilepsy and different MTHFR C677T genotypes. 114
Non-resective surgery and radiosurgery for treatment of drug-resistant epilepsy 114
Low penetrance and effect on protein secretionof LGI1 mutations causing autosomal dominantlateral temporal epilepsy 113
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations 111
Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. 110
Short-term nonhormonal and nonsteroid treatment in West syndrome. 108
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label,randomized, parallel-group study 107
Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. 106
Obese children suffer more often from migraine 106
Nutritional problems in children with neuromotor disabilities: an Italian case series. 106
Anticonvulsant drugs for generalized tonic-clonic epilepsy 106
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy. 105
Benign idiopathic partial seizures in the velocardiofacial syndrome: report of two cases. 103
Update on rufinamide in childhood epilepsy 102
Efficacy and tolerability of levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy 102
Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure 102
Peri-ictal and inter-ictal headache in children and adolescents with idiopathic epilepsy: a multicenter cross-sectional study. 101
Neonatal hyperekplexia: a case report. 101
Oral-facial-digital syndrome type VI: is C5orf42 really the major gene? 100
The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. 98
The metabolic syndrome in overweight epileptic patients treated with valproic acid. 97
Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial 97
Antiepileptic drug withdrawal in childhood epilepsy: What are the riskfactors associated with seizure relapse? 97
Idiopathic generalized tonic-clonic epilepsy and photosensitivity: a long-term follow-up study. 96
Bone mineral density in angelman syndrome. 96
West syndrome associated with 14q12 duplications harboring FOXG1 96
Teachers of various school grades and representations of epilepsy: problems, relational aspects and perspectives of life quality 96
Update of the medical treatment of West syndrome. 95
Should "migralepsy" be considered an obsolete concept? A multicenter retrospective clinical/EEG study and review of the literature. 95
Levetiracetam in monoterapia o add-on in bambini e adolescenti con epilessia: follow-up a medio e lungo termine 95
Effects of the abrupt switch from solution tomodified-release granule formulation of valproate 95
Notions And Representations Of Epilepsy Syndrome: An Exploratory StudyWith Female Teachers In Campania 95
[Electroencephalographic aspects of pediatric brain tumors. Considerations in 151 cases] 94
Canali del potassio e la genetica delle convulsioni familiari neonatali benigne 94
Epilepsy, sex hormones and antiepileptic drugs in females 93
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. 93
[Marfan's syndrome: clinical diagnostic criteria with a case report] 93
Reflex myoclonic epilepsy in infancy: a multicenter clinical study. 93
Cerebellar vermis defect, oligophrenia, congenital ataxia, and hepatic fibrocirrhosis without coloboma and renal abnormalities: report of three cases. 92
Epilessia parziale benigna nella sindrome di Shprintzen: presentazione di due casi. 92
Quale ruolo per i barbiturici nell’anno 2000? 92
Neuropsychological profiles and outcomes in children with new onset frontal lobe epilepsy 92
Perampanel tolerability in children and adolescents with focal epilepsy: Effects on behavior and executive functions 92
Lacosamide in pediatric and adult patients: comparison of efficacy and safety 92
Ketogenic diet and epilepsy: an up-date review. 91
Argomenti di Neuropsichiatria Infantile. 91
Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial. 91
Refractory absence seizures: An Italian multicenter retrospective study 91
Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. 90
New antiepileptic drugs in the treatment of Lennox-Gastaut syndrome 90
Il Vigabatrin nel trattamento delle epilessie farmacoresistenti in età evolutiva: presentazione di uno studio su 77 casi 90
Efficacy and safety of levetiracetam: An add-on trial in children with refractory epilepsy. 89
Totale 15.054
Categoria #
all - tutte 70.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.394 0 0 0 9 185 103 189 18 188 15 229 458
2021/20221.365 4 29 7 20 21 23 15 66 217 191 165 607
2022/20232.172 229 109 27 244 319 492 0 248 327 20 110 47
2023/2024687 80 117 52 40 41 66 14 46 2 20 46 163
2024/20251.711 84 16 25 54 89 283 167 214 308 81 179 211
2025/20265.948 512 2.453 2.902 81 0 0 0 0 0 0 0 0
Totale 23.076